Focused Research Themes
Human Tumor Virology
Gut Microbiota & Microbiome
Antimicrobial Resistance and Antibiotic Stewardship
Streptococcus pneumoniae and Other Streptococci
HPV Research & Education Consortium @ CU Medicine
 
 
 
Research > HPV Research & Education Consortium @ CU Medicine
HPV Research & Education Consortium @ CU Medicine
 
About Us | People | Collaborators | Education Resources | Programs | Useful Links | Publications
 
Publications
  1. Lee A, Wong MC, Chan TT, Chan PK. A home-school-doctor model to break the barriers for uptake of human papillomavirus vaccine. BMC Public Health. 2015 Sep 21;15(1):935. doi: 10.1186/s12889-015-2269-1.
  2. Chor JS, Vlantis AC, Chow TL, Fung SC, Ng FY, Lau CH, Chan AB, Ho LC, Kwong WH, Fung MN, Lam EW, Mak KL, Lam HC, Kok AS, Ho WC, Yeung AC, Chan PK. The role of human papillomavirus in head and neck squamous cell carcinoma: A case control study on a southern Chinese population. J Med Virol. 2015 Oct 15. doi: 10.1002/jmv.24405. [Epub ahead of print]
  3. Lau YM, Cheung TH, Yeo W, Mo F, Yu MY, Lee KM, Ho WC, Yeung AC, Law PT, Chan PK. Prognostic implication of human papillomavirus types and species in cervical cancer patients undergoing primary treatment. PLoS One. 2015 Apr 9;10(4):e0122557. doi: 10.1371/journal.pone.0122557. eCollection 2015.
  4. Wong EL, Chan PK, Chor JS, Cheung AW, Huang F, Wong SY. Evaluation of the Impact of Human Papillomavirus DNA Self-sampling on the Uptake of Cervical Cancer Screening. Cancer Nurs. 2015 Feb 27. [Epub ahead of print]
  5. Chung TK, Van Hummelen P, Chan PK, Cheung TH, Yim SF, Yu MY, Ducar MD, Thorner AR, MacConaill LE, Doran G, Pedamallu CS, Ojesina AI, Wong RR, Wang VW, Freeman SS, Lau TS, Kwong J, Chan LK, Fromer M, May T, Worley MJ Jr, Esselen KM, Elias KM, Lawrence M, Getz G, Smith DI, Crum CP, Meyerson M, Berkowitz RS, Wong YF.Genomic aberrations in cervical adenocarcinomas in Hong Kong Chinese women. Int J Cancer. 2015 Jan 27. doi: 10.1002/ijc.29456. [Epub ahead of print]
  6. Chan PK, Ho WC, Chan MC, Wong MC, Yeung AC, Chor JS, Hui M. Meta-analysis on prevalence and attribution of human papillomavirus types 52 and 58 in cervical neoplasia worldwide. PLoS One. 2014 Sep 17;9(9):e107573. doi: 10.1371/journal.pone.0107573. eCollection 2014.
  7. Zhang C, Park JS, Grce M, Hibbitts S, Palefsky JM, Konno R, Smith-McCune KK, Giovannelli L, Chu TY, Picconi MA, Piña-Sánchez P, Settheetham-Ishida W, Coutlée F, De Marco F, Woo YL, Ho WC, Wong MC, Chirenje MZ, Magure T, Moscicki AB, Sabol I, Fiander AN, Chen Z, Chan MC, Cheung TH, Burk RD, Chan PK. Geographical distribution and risk association of human papillomavirus genotype 52-variant lineages. J Infect Dis. 2014 Nov 15;210(10):1600-4. doi: 10.1093/infdis/jiu310. Epub 2014 May 30.
  8. Jelen MM, Chen Z, Kocjan BJ, Burt FJ, Chan PK, Chouhy D, Combrinck CE, Coutlée F, Estrade C, Ferenczy A, Fiander A, Franco EL, Garland SM, Giri AA, González JV, Gröning A, Heidrich K, Hibbitts S, Hošnjak L, Luk TN, Marinic K, Matsukura T, Neumann A, Oštrbenk A, Picconi MA, Richardson H, Sagadin M, Sahli R, Seedat RY, Seme K, Severini A, Sinchi JL, Smahelova J, Tabrizi SN, Tachezy R, Tohme S, Uloza V, Vitkauskiene A, Wong YW, Zidovec Lepej S, Burk RD, Poljak M. Global genomic diversity of human papillomavirus 6 based on 724 isolates and 190 complete genome sequences. J Virol. 2014 Jul;88(13):7307-16. doi: 10.1128/JVI.00621-14. Epub 2014 Apr 16.
  9. Cheung JL, Cheung TH, Yu MY, Chan PK. Virological characteristics of cervical cancers carrying pure episomal form of HPV16 genome. Gynecol Oncol. 2013 Nov;131(2):374-9. doi: 10.1016/j.ygyno.2013.08.026. Epub 2013 Sep 5.
  10. Wong MC, Lee A, Ngai KL, Chor JC, Chan PK. Knowledge, attitude, practice and barriers on vaccination against human papillomavirus infection: a cross-sectional study among primary care physicians in Hong Kong. PLoS One. 2013 Aug 21;8(8):e71827. doi: 10.1371/journal.pone.0071827. eCollection 2013.
  11. Nelson EA, Lam HS, Choi KC, Ho WC, Fung LW, Cheng FW, Sung RY, Royals M, Chan PK. A pilot randomized study to assess immunogenicity, reactogenicity, safety and tolerability of two human papillomavirus vaccines administered intramuscularly and intradermally to females aged 18-26 years. Vaccine. 2013 Jul 25;31(34):3452-60. doi: 10.1016/j.vaccine.2013.06.034. Epub 2013 Jun 12.
  12. Chan PK, Zhang C, Park JS, Smith-McCune KK, Palefsky JM, Giovannelli L, Coutlée F, Hibbitts S, Konno R, Settheetham-Ishida W, Chu TY, Ferrera A, Alejandra Picconi M, De Marco F, Woo YL, Raiol T, Piña-Sánchez P, Bae JH, Wong MC, Chirenje MZ, Magure T, Moscicki AB, Fiander AN, Capra G, Young Ki E, Tan Y, Chen Z, Burk RD, Chan MC, Cheung TH, Pim D, Banks L. Geographical distribution and oncogenic risk association of human papillomavirus type 58 E6 and E7 sequence variations. Int J Cancer. 2013 Jun 1;132(11):2528-36. doi: 10.1002/ijc.27932. Epub 2012 Nov 29.
  13. Chan PK, Picconi MA, Cheung TH, Giovannelli L, Park JS. Laboratory and clinical aspects of human papillomavirus testing. Crit Rev Clin Lab Sci. 2012 Jul-Aug;49(4):117-36. doi: 10.3109/10408363.2012.707174. Review.
  14. Ma ST, Yeung AC, Chan PK, Graham CA. Transvaginal ultrasound probe contamination by the human papillomavirus in the emergency department. Emerg Med J. 2013 Jun;30(6):472-5. doi: 10.1136/emermed-2012-201407. Epub 2012 Jul 3.
  15. Chan PK. Human papillomavirus type 58: the unique role in cervical cancers in East Asia. Cell Biosci. 2012 May 9;2(1):17. doi: 10.1186/2045-3701-2-17.
  16. Yu SL, Chan PK, Wong CK, Szeto CC, Ho SC, So K, Yu MM, Yim SF, Cheung TH, Wong MC, Cheung JL, Yeung AC, Li EK, Tam LS. Antagonist-mediated down-regulation of Toll-like receptors increases the prevalence of human papillomavirus infection in systemic lupus erythematosus. Arthritis Res Ther. 2012 Apr 18;14(2):R80. doi: 10.1186/ar3803.
  17. Chan PK, Cheung TH, Li WH, Yu MY, Chan MY, Yim SF, Ho WC, Yeung AC, Ho KM, Ng HK. Attribution of human papillomavirus types to cervical intraepithelial neoplasia and invasive cancers in Southern China. Int J Cancer. 2012 Aug 1;131(3):692-705. doi: 10.1002/ijc.26404. Epub 2011 Oct 5.
  18. Sham CL, To KF, Chan PK, Lee DL, Tong MC, van Hasselt CA. Prevalence of human papillomavirus, Epstein-Barr virus, p21, and p53 expression in sinonasal inverted papilloma, nasal polyp, and hypertrophied turbinate in Hong Kong patients. Head Neck. 2012 Apr;34(4):520-33. doi: 10.1002/hed.21772. Epub 2011 May 23.
  19. Chan PK, Luk AC, Park JS, Smith-McCune KK, Palefsky JM, Konno R, Giovannelli L, Coutlée F, Hibbitts S, Chu TY, Settheetham-Ishida W, Picconi MA, Ferrera A, De Marco F, Woo YL, Raiol T, Piña-Sánchez P, Cheung JL, Bae JH, Chirenje MZ, Magure T, Moscicki AB, Fiander AN, Di Stefano R, Cheung TH, Yu MM, Tsui SK, Pim D, Banks L. Identification of human papillomavirus type 58 lineages and the distribution worldwide. J Infect Dis. 2011 Jun 1;203(11):1565-73. doi: 10.1093/infdis/jir157.
  20. Chan PK, Liu SJ, Cheung JL, Cheung TH, Yeo W, Chong P, Man S. T-cell response to human papillomavirus type 52 L1, E6, and E7 peptides in women with transient infection, cervical intraepithelial neoplasia, and invasive cancer. J Med Virol. 2011 Jun;83(6):1023-30. doi: 10.1002/jmv.21889.
  21. Tam LS, Chan PK, Ho SC, Yu MY, Yim SF, Cheung TH, Wong MC, Cheung JL, Li EK. Risk factors for squamous intraepithelial lesions in systemic lupus erythematosus: a prospective cohort study. Arthritis Care Res (Hoboken). 2011 Feb;63(2):269-76. doi: 10.1002/acr.20367.
  22. Yip YC, Ngai KL, Vong HT, Tzang LC, Ji S, Yang M, Chan PK. Prevalence and genotype distribution of cervical human papillomavirus infection in Macao. J Med Virol. 2010 Oct;82(10):1724-9. doi: 10.1002/jmv.21826.
  23. Chan PK, Liu SJ, Cheung TH, Yeo W, Ngai SM, Cheung JL, Chong P, Man S.T-cell response to human papillomavirus type 58 L1, E6, And E7 peptides in women with cleared infection, cervical intraepithelial neoplasia, or invasive cancer. Clin Vaccine Immunol. 2010 Sep;17(9):1315-21. doi: 10.1128/CVI.00105-10. Epub 2010 Jul 28.
  24. Hlaing T, Yip YC, Ngai KL, Vong HT, Wong SI, Ho WC, Batalha SL, Chan PK. Distribution of human papillomavirus genotypes among cervical intraepithelial neoplasia and invasive cancers in Macao. J Med Virol. 2010 Sep;82(9):1600-5. doi: 10.1002/jmv.21847.
  25. Tam LS, Chan PK, Ho SC, Yu MM, Yim SF, Cheung TH, Wong MC, Li EK. Natural history of cervical papilloma virus infection in systemic lupus erythematosus - a prospective cohort study. J Rheumatol. 2010 Feb;37(2):330-40. doi: 10.3899/jrheum.090644. Epub 2009 Dec 23.
  26. Wong WC, Fong B, Chan PK. Acceptance of human papillomavirus vaccination among first year female university students in Hong Kong. Sex Health. 2009 Dec;6(4):264-71. doi: 10.1071/SH09017.
  27. Bae JH, Cheung JL, Lee SJ, Luk AC, Tong SY, Chan PK, Park JS. Distribution of human papillomavirus type 58 variants in progression of cervical dysplasia in Korean women. J Microbiol Biotechnol. 2009 Sep;19(9):1051-4.
  28. Chan PK, Ho WC, Wong MC, Chang AR, Chor JS, Yu MY. Epidemiologic risk profile of infection with different groups of human papillomaviruses. J Med Virol. 2009 Sep;81(9):1635-44. doi: 10.1002/jmv.21575.
  29. Chan PK, Chang AR, Yu MY, Li WH, Chan MY, Yeung AC, Cheung TH, Yau TN, Wong SM, Yau CW, Ng HK. Age distribution of human papillomavirus infection and cervical neoplasia reflects caveats of cervical screening policies. Int J Cancer. 2010 Jan 1;126(1):297-301. doi: 10.1002/ijc.24731.
  30. Chan PK, Ho WC, Yu MY, Pong WM, Chan AC, Chan AK, Cheung TH, Wong MC, To KF, Ng HK. Distribution of human papillomavirus types in cervical cancers in Hong Kong: current situation and changes over the last decades. Int J Cancer. 2009 Oct 1;125(7):1671-7. doi: 10.1002/ijc.24495.
  31. Chan PK, Luk AC, Luk TN, Lee KF, Cheung JL, Ho KM, Lo KK. Distribution of human papillomavirus types in anogenital warts of men. J Clin Virol. 2009 Feb;44(2):111-4. doi: 10.1016/j.jcv.2008.11.001. Epub 2008 Dec 18.
  32. Cheung JL, Cheung TH, Ng CW, Yu MY, Wong MC, Siu SS, Yim SF, Chan PK. Analysis of human papillomavirus type 18 load and integration status from low-grade cervical lesion to invasive cervical cancer. J Clin Microbiol. 2009 Feb;47(2):287-93. doi: 10.1128/JCM.01531-08. Epub 2008 Nov 26.
  33. Cheung JL, Cheung TH, Tang JW, Chan PK. Increase of integration events and infection loads of human papillomavirus type 52 with lesion severity from low-grade cervical lesion to invasive cancer. J Clin Microbiol. 2008 Apr;46(4):1356-62. doi: 10.1128/JCM.01785-07. Epub 2008 Feb 13.
  34. Chan PK, Cheung JL, Cheung TH, Lo KW, Yim SF, Siu SS, Tang JW. Profile of viral load, integration, and E2 gene disruption of HPV58 in normal cervix and cervical neoplasia. J Infect Dis. 2007 Sep 15;196(6):868-75. Epub 2007 Aug 6.
  35. Siu SS, Cheung TH, Chan PK, Lin CK, Lo KW. Patients with malignant or pre-malignant cervical lesion have increased risk of becoming hepatitis B carrier. J Exp Clin Cancer Res. 2007 Mar;26(1):77-81.
  36. Chan PK, Cheung TH, Lin CK, Siu SS, Yim SF, Lo KW, Cheung JL, Tam AO, Tang JW. Association between HLA-DRB1 polymorphism, high-risk HPV infection and cervical neoplasia in southern Chinese. J Med Virol. 2007 Jul;79(7):970-6.
  37. Chan PK, Cheung JL, Cheung TH, Lin CK, Siu SS, Yu MM, Tang JW, Lo KW, Yim SF, Wong YF, To KF, Ng HK, Chung TK. HLA-DQB1 polymorphisms and risk for cervical cancer: a case-control study in a southern Chinese population. Gynecol Oncol. 2007 Jun;105(3):736-41. Epub 2007 Mar 26.
  38. Cheung JL, Lo KW, Cheung TH, Tang JW, Chan PK. Viral load, E2 gene disruption status, and lineage of human papillomavirus type 16 infection in cervical neoplasia. J Infect Dis. 2006 Dec 15;194(12):1706-12. Epub 2006 Nov 3.
  39. Chan DP, Cheung TH, Tam AO, Cheung JL, Yim SF, Lo KW, Siu NS, Zhou DX, Chan PK. Risk association between human leukocyte antigen-A allele and high-risk human papillomavirus infection for cervical neoplasia in Chinese women. J Infect Dis. 2005 Nov 15;192(10):1749-56. Epub 2005 Oct 7.
  40. Chan PK, Cheung JL, Cheung TH, Lin CK, Tam AO, Chan DP, Zhou DX, Lo KW, Yim SF, Siu SS. HLA-B alleles, high-risk HPV infection and risk for cervical neoplasia in southern Chinese women. Int J Cancer. 2006 Mar 15;118(6):1430-5.
  41. Chan PK, Cheung TH, Tam AO, Lo KW, Yim SF, Yu MM, To KF, Wong YF, Cheung JL, Chan DP, Hui M, Ip M. Biases in human papillomavirus genotype prevalence assessment associated with commonly used consensus primers. Int J Cancer. 2006 Jan 1;118(1):243-5.
  42. Chan PK, Yu MM, Cheung TH, To KF, Lo KW, Cheung JL, Tong JH. Detection and quantitation of human papillomavirus DNA in primary tumour and lymph nodes of patients with early stage cervical carcinoma. J Clin Virol. 2005 Jul;33(3):201-5. Epub 2004 Dec 15.
  43. Tam LS, Chan AY, Chan PK, Chang AR, Li EK. Increased prevalence of squamous intraepithelial lesions in systemic lupus erythematosus: association with human papillomavirus infection. Arthritis Rheum. 2004 Nov;50(11):3619-25.
  44. Du J, Chen GG, Vlantis AC, Chan PK, Tsang RK, van Hasselt CA. Resistance to apoptosis of HPV 16-infected laryngeal cancer cells is associated with decreased Bak and increased Bcl-2 expression. Cancer Lett. 2004 Mar 8;205(1):81-8.
  45. Yu MY, Tong JH, Chan PK, Lee TL, Chan MW, Chan AW, Lo KW, To KF. Hypermethylation of the tumor suppressor gene RASSFIA and frequent concomitant loss of heterozygosity at 3p21 in cervical cancers. Int J Cancer. 2003 Jun 10;105(2):204-9.
  46. Chan PK, Mak KH, Cheung JL, Tang NL, Chan DP, Lo KK, Cheng AF. Genotype spectrum of cervical human papillomavirus infection among sexually transmitted disease clinic patients in Hong Kong. J Med Virol. 2002 Oct;68(2):273-7.
  47. Chan PK, Lam CW, Cheung TH, Li WW, Lo KW, Chan MY, Cheung JL, Xu LY, Cheng AF Human papillomavirus type 16 intratypic variant infection and risk for cervical neoplasia in southern China. J Infect Dis. 2002 Sep 1;186(5):696-700. Epub 2002 Aug 5.
  48. Chan PK, Lam CW, Cheung TH, Li WW, Lo KW, Chan MY, Cheung JL, Cheng AF. Association of human papillomavirus type 58 variant with the risk of cervical cancer. J Natl Cancer Inst. 2002 Aug 21;94(16):1249-53.
  49. Chan PK, Chang AR, Tam WH, Cheung JL, Cheng AF. Prevalence and genotype distribution of cervical human papillomavirus infection: Comparison between pregnant women and non-pregnant controls. J Med Virol. 2002 Aug;67(4):583-8.
  50. Chan PK, Chang AR, Cheung JL, Chan DP, Xu LY, Tang NL, Cheng AF. Determinants of cervical human papillomavirus infection: differences between high- and low-oncogenic risk types. J Infect Dis. 2002 Jan 1;185(1):28-35. Epub 2001 Dec 5.
  51. Chan PK, Chan DP, To KF, Yu MY, Cheung JL, Cheng AF. Evaluation of extraction methods from paraffin wax embedded tissues for PCR amplification of human and viral DNA. J Clin Pathol. 2001 May;54(5):401-3.
  52. Chan PK, Chan MY, Li WW, Chan DP, Cheung JL, Cheng AF. Association of human beta-herpesviruses with the development of cervical cancer: bystanders or cofactors. J Clin Pathol. 2001 Jan;54(1):48-53.
  53. Chan PK, Li WH, Chan MY, Ma WL, Cheung JL, Cheng AF. High prevalence of human papillomavirus type 58 in Chinese women with cervical cancer and precancerous lesions. J Med Virol. 1999 Oct;59(2):232-8.
  54. Chen Z, de Freitas LB, Burk RD. Evolution and classification of oncogenic human papillomavirus types and variants associated with cervical cancer. Methods Mol Biol. 2015;1249:3-26. doi: 10.1007/978-1-4939-2013-6_1.
  55. Mirabello L, Frimer M, Harari A, McAndrew T, Smith B, Chen Z, Wentzensen N, Wacholder S, Castle PE, Raine-Bennett T, Schiffman M, Burk RD. HPV16 methyl-haplotypes determined by a novel next-generation sequencing method are associated with cervical precancer. Int J Cancer. 2015 Feb 15;136(4):E146-53. doi: 10.1002/ijc.29119. Epub 2014 Sep 3.
  56. Freitas LB, Chen Z, Muqui EF, Boldrini NA, Miranda AE, Spano LC, Burk RD. Human papillomavirus 16 non-European variants are preferentially associated with high-grade cervical lesions. PLoS One. 2014 Jul 1;9(7):e100746. doi: 10.1371/journal.pone.0100746. eCollection 2014.
  57. Sun C, McAndrew T, Smith BC, Chen Z, Frimer M, Burk RD. Characterization of HPV DNA methylation of contiguous CpG sites by bisulfite treatment and massively parallel sequencing-the FRAGMENT approach. Front Genet. 2014 Jun 3;5:150. doi: 10.3389/fgene.2014.00150. eCollection 2014.
  58. Jelen MM, Chen Z, Kocjan BJ, Burt FJ, Chan PK, Chouhy D, Combrinck CE, Coutlée F, Estrade C, Ferenczy A, Fiander A, Franco EL, Garland SM, Giri AA, González JV, Gröning A, Heidrich K, Hibbitts S, Hošnjak L, Luk TN, Marinic K, Matsukura T, Neumann A, Oštrbenk A, Picconi MA, Richardson H, Sagadin M, Sahli R, Seedat RY, Seme K, Severini A, Sinchi JL, Smahelova J, Tabrizi SN, Tachezy R, Tohme S, Uloza V, Vitkauskiene A, Wong YW, Zidovec Lepej S, Burk RD, Poljak M. Global genomic diversity of human papillomavirus 6 based on 724 isolates and 190 complete genome sequences. J Virol. 2014 Jul;88(13):7307-16. doi: 10.1128/JVI.00621-14. Epub 2014 Apr 16.
  59. Harari A, Chen Z, Burk RD. Human papillomavirus genomics: past, present and future. Curr Probl Dermatol. 2014;45:1-18. doi: 10.1159/000355952. Epub 2014 Mar 13.
  60. Chen AA, Heideman DA, Boon D, Chen Z, Burk RD, De Vuyst H, Gheit T, Snijders PJ, Tommasino M, Franceschi S, Clifford GM. Human papillomavirus 33 worldwide genetic variation and associated risk of cervical cancer. Virology. 2014 Jan 5;448:356-62. doi: 10.1016/j.virol.2013.10.033. Epub 2013 Nov 12.
  61. Burk RD, Harari A, Chen Z. Human papillomavirus genome variants. Virology. 2013 Oct;445(1-2):232-43. doi: 10.1016/j.virol.2013.07.018. Epub 2013 Aug 31. Review.
  62. Chen Z, Schiffman M, Herrero R, DeSalle R, Anastos K, Segondy M, Sahasrabuddhe VV, Gravitt PE, Hsing AW, Burk RD. Evolution and taxonomic classification of alphapapillomavirus 7 complete genomes: HPV18, HPV39, HPV45, HPV59, HPV68 and HPV70. PLoS One. 2013 Aug 16;8(8):e72565. doi: 10.1371/journal.pone.0072565. eCollection 2013.
  63. Fatahzadeh M, Schlecht NF, Chen Z, Bottalico D, McKinney S, Ostoloza J, Dunne A, Burk RD. Oral human papillomavirus detection in older adults who have human immunodeficiency virus infection. Oral Surg Oral Med Oral Pathol Oral Radiol. 2013 Apr;115(4):505-14. doi: 10.1016/j.oooo.2012.11.004. Epub 2013 Jan 31.
  64. Smith BC, McAndrew T, Chen Z, Harari A, Barris DM, Viswanathan S, Rodriguez AC, Castle P, Herrero R, Schiffman M, Burk RD. The cervical microbiome over 7 years and a comparison of methodologies for its characterization. PLoS One. 2012;7(7):e40425. doi: 10.1371/journal.pone.0040425. Epub 2012 Jul 9.
  65. Bottalico D, Chen Z, Kocjan BJ, Seme K, Poljak M, Burk RD. Characterization of human papillomavirus type 120: a novel betapapillomavirus with tropism for multiple anatomical niches. J Gen Virol. 2012 Aug;93(Pt 8):1774-9. doi: 10.1099/vir.0.041897-0. Epub 2012 May 2.
  66. Burk RD, Chen Z, Harari A, Smith BC, Kocjan BJ, Maver PJ, Poljak M. Classification and nomenclature system for human Alphapapillomavirus variants: general features, nucleotide landmarks and assignment of HPV6 and HPV11 isolates to variant lineages. Acta Dermatovenerol Alp Pannonica Adriat. 2011 Sep;20(3):113-23.
  67. Bottalico D, Chen Z, Dunne A, Ostoloza J, McKinney S, Sun C, Schlecht NF, Fatahzadeh M, Herrero R, Schiffman M, Burk RD. The oral cavity contains abundant known and novel human papillomaviruses from the Betapapillomavirus and Gammapapillomavirus genera. J Infect Dis. 2011 Sep 1;204(5):787-92. doi: 10.1093/infdis/jir383.
  68. Smith B, Chen Z, Reimers L, van Doorslaer K, Schiffman M, Desalle R, Herrero R, Yu K, Wacholder S, Wang T, Burk RD. Sequence imputation of HPV16 genomes for genetic association studies. PLoS One. 2011;6(6):e21375. doi: 10.1371/journal.pone.0021375. Epub 2011 Jun 23.
  69. Chen Z, Schiffman M, Herrero R, Desalle R, Anastos K, Segondy M, Sahasrabuddhe VV, Gravitt PE, Hsing AW, Burk RD. Evolution and taxonomic classification of human papillomavirus 16 (HPV16)-related variant genomes: HPV31, HPV33, HPV35, HPV52, HPV58 and HPV67. PLoS One. 2011;6(5):e20183. doi: 10.1371/journal.pone.0020183. Epub 2011 May 27.
  70. Fu L, Van Doorslaer K, Chen Z, Ristriani T, Masson M, Travé G, Burk RD. Degradation of p53 by human Alphapapillomavirus E6 proteins shows a stronger correlation with phylogeny than oncogenicity. PLoS One. 2010 Sep 17;5(9). pii: e12816. doi: 10.1371/journal.pone.0012816.
  71. Schiffman M, Rodriguez AC, Chen Z, Wacholder S, Herrero R, Hildesheim A, Desalle R, Befano B, Yu K, Safaeian M, Sherman ME, Morales J, Guillen D, Alfaro M, Hutchinson M, Solomon D, Castle PE, Burk RD. A population-based prospective study of carcinogenic human papillomavirus variant lineages, viral persistence, and cervical neoplasia. Cancer Res. 2010 Apr 15;70(8):3159-69. doi: 10.1158/0008-5472.CAN-09-4179. Epub 2010 Mar 30.
  72. Safaeian M, van Doorslaer K, Schiffman M, Chen Z, Rodriguez AC, Herrero R, Hildesheim A, Burk RD. Lack of heterogeneity of HPV16 E7 sequence compared with HPV31 and HPV73 may be related to its unique carcinogenic properties. Arch Virol. 2010 Mar;155(3):367-70. doi: 10.1007/s00705-009-0579-2. Epub 2010 Jan 6.
  73. Burk RD, Chen Z, Van Doorslaer K. Human papillomaviruses: genetic basis of carcinogenicity. Public Health Genomics. 2009;12(5-6):281-90. doi: 10.1159/000214919. Epub 2009 Aug 11. Review.
  74. Blakaj DM, Fernandez-Fuentes N, Chen Z, Hegde R, Fiser A, Burk RD, Brenowitz M. Evolutionary and biophysical relationships among the papillomavirus E2 proteins. Front Biosci (Landmark Ed). 2009 Jan 1;14:900-17. Review.
  75. Chen Z, DeSalle R, Schiffman M, Herrero R, Burk RD.Evolutionary dynamics of variant genomes of human papillomavirus types 18, 45, and 97. J Virol. 2009 Feb;83(3):1443-55. doi: 10.1128/JVI.02068-08. Epub 2008 Nov 26.
  76. Haddad R, Crum C, Chen Z, Krane J, Posner M, Li Y, Burk R. HPV16 transmission between a couple with HPV-related head and neck cancer. Oral Oncol. 2008 Aug;44(8):812-5. Epub 2007 Dec 3.
  77. Chen Z, Schiffman M, Herrero R, Burk RD. Identification and characterization of two novel human papillomaviruses (HPVs) by overlapping PCR: HPV102 and HPV106. J Gen Virol. 2007 Nov;88(Pt 11):2952-5.
  78. Wood CE, Chen Z, Cline JM, Miller BE, Burk RD. Characterization and experimental transmission of an oncogenic papillomavirus in female macaques. J Virol. 2007 Jun;81(12):6339-45. Epub 2007 Apr 11.
  79. Chen Z, Fu L, Herrero R, Schiffman M, Burk RD. Identification of a novel human papillomavirus (HPV97) related to HPV18 and HPV45. Int J Cancer. 2007 Jul 1;121(1):193-8.
  80. Chen Z, Schiffman M, Herrero R, Desalle R, Burk RD. Human papillomavirus (HPV) types 101 and 103 isolated from cervicovaginal cells lack an E6 open reading frame (ORF) and are related to gamma-papillomaviruses. Virology. 2007 Apr 10;360(2):447-53. Epub 2006 Nov 22.
  81. Narechania A, Chen Z, DeSalle R, Burk RD. Phylogenetic incongruence among oncogenic genital alpha human papillomaviruses. J Virol. 2005 Dec;79(24):15503-10.
  82. Schlecht NF, Burk RD, Palefsky JM, Minkoff H, Xue X, Massad LS, Bacon M, Levine AM, Anastos K, Gange SJ, Watts DH, Da Costa MM, Chen Z, Bang JY, Fazzari M, Hall C, Strickler HD. Variants of human papillomaviruses 16 and 18 and their natural history in human immunodeficiency virus-positive women. J Gen Virol. 2005 Oct;86(Pt 10):2709-20.
  83. Schiffman M, Herrero R, Desalle R, Hildesheim A, Wacholder S, Rodriguez AC, Bratti MC, Sherman ME, Morales J, Guillen D, Alfaro M, Hutchinson M, Wright TC, Solomon D, Chen Z, Schussler J, Castle PE, Burk RD. The carcinogenicity of human papillomavirus types reflects viral evolution. Virology. 2005 Jun 20;337(1):76-84.
  84. Tong TR, Yau RW, Chan OW, Yu V, Lo JW, Chow TC, Chan BW, Lee KC. Cervical Cancer Screening for the Reluctant - HPV Testing of Air-Dried Vaginal Discharge.Int J Biomed Sci. 2006 Dec;2(4):422-7. 2006 Dec;2(4):422-7.
  85. Lee A, Ho M, Cheung CK, Keung VM. Factors influencing adolescent girls' decision in initiation for human papillomavirus vaccination: a cross-sectional study in Hong Kong. BMC Public Health. 2014 Sep 8;14:925. doi: 10.1186/1471-2458-14-925.
  86. Liu HC, Chen GG, Vlantis AC, Tse GM, Chan AT, van Hasselt CA. Inhibition of apoptosis in human laryngeal cancer cells by E6 and E7 oncoproteins of human papillomavirus 16. J Cell Biochem. 2008 Mar 1;103(4):1125-43.
  87. Du J, Chen GG, Vlantis AC, Xu H, Tsang RK, van Hasselt AC. The nuclear localization of NFkappaB and p53 is positively correlated with HPV16 E7 level in laryngeal squamous cell carcinoma. J Histochem Cytochem. 2003 Apr;51(4):533-9.